CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with EGFR-Mutant Non-small Cell Lung Cancer
Jong Ho Cho, Wei Zhou, Yoon-La Choi, Jong-Mu Sun, Hyejoo Choi, Tae-Eun Kim, Marisa Dolled-Filhart, Kenneth Emancipator, Mary Anne Rutkowski, Jhingook Kim
Cancer Research and Treatment. 2018;50(1):95-102.   Published online 2017 March 17    DOI: https://doi.org/10.4143/crt.2016.591

Excel Download

Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with EGFR-Mutant Non-small Cell Lung Cancer
Cancer Research and Treatment. 2018;50(1):95-102   Crossref logo
Link1 Link2 Link3

MYC expression correlates with PD-L1 expression in non-small cell lung cancer
Lung Cancer. 2017;110:63-67   Crossref logo
Link1 Link2

Impact of cytotoxic chemotherapy on PD-L1 expression in patients with non–small cell lung cancer negative for EGFR mutation and ALK fusion
Lung Cancer. 2019;127:59-65   Crossref logo
Link1 Link2

The clinical utility of PD-L1 testing in selecting non-small cell lung cancer patients for PD1/PD-L1-directed therapy
Clinical Pharmacology & Therapeutics. 2016;100(3):212-214   Crossref logo
Link1 Link2

13 EGFR-mutation analysis, treatment and outcomes in newly diagnosed patients with non-small cell lung cancer (NSCLC): a single-institution retrospective review
Lung Cancer. 2012;75:S5   Crossref logo
Link1 Link2

Biomarkers for PD-1/PD-L1 Blockade Therapy in Non–Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?
Clinical Lung Cancer. 2016;17(5):350-361   Crossref logo
Link1 Link2

MA15.01 Strong PD-L1 Expression Predicts Poor Response and de Novo Resistance to EGFR TKIs Among Non-Small Cell Lung Cancer Patients with EGFR Mutation
Journal of Thoracic Oncology. 2018;13(10):S407   Crossref logo
Link1 Link2

P1.04-18 PD-L1 Expression and its Correlation with Tumor TNM Stage in Patients with Non-Small Cell Lung Cancer
Journal of Thoracic Oncology. 2018;13(10):S532   Crossref logo
Link1 Link2

Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non–small cell lung cancer
Lung Cancer. 2016;99:79-87   Crossref logo
Link1 Link2

PD-L1 on peripheral blood T lymphocytes is prognostic in patients with non-small cell lung cancer (NSCLC) treated with EGFR inhibitors
Lung Cancer. 2016;93:9-16   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.